Bank Of America Corp Prelude Therapeutics Inc Transaction History

Bank Of America Corp

$1.21 Trillion
Q1 2025

A detailed history of Bank Of America Corp transactions in Prelude Therapeutics Inc stock. As of the latest transaction made, Bank Of America Corp holds 15,446 shares of PRLD stock, worth $14,210. This represents 0.0% of its overall portfolio holdings.

Number of Shares

15,446

Previous 20,654 25.22%

Holding current value

$14,210

Previous $26,000 57.69%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.64 - $1.39 $3,333 - $7,239	-5,208 Reduced 25.22%	15,446 $11,000
Q4 2024 Feb 14, 2025	SELL	$0.8 - $2.04 $3,432 - $8,751	-4,290 Reduced 17.2%	20,654 $26,000
Q3 2024 Nov 14, 2024	SELL	$2.07 - $6.37 $19,321 - $59,457	-9,334 Reduced 27.23%	24,944 $51,000
Q2 2024 Aug 14, 2024	BUY	$3.32 - $5.63 $6,686 - $11,338	2,014 Added 6.24%	34,278 $130,000
Q1 2024 May 15, 2024	SELL	$2.68 - $4.84 $14,005 - $25,293	-5,226 Reduced 13.94%	32,264 $152,000
Q4 2023 Feb 14, 2024	BUY	$1.69 - $4.37 $43,940 - $113,620	26,000 Added 226.28%	37,490 $160,000
Q2 2023 Aug 14, 2023	SELL	$4.45 - $8.12 $74,297 - $135,571	-16,696 Reduced 59.24%	11,490 $51,000
Q1 2023 May 12, 2023	SELL	$4.58 - $7.34 $593,742 - $951,542	-129,638 Reduced 82.14%	28,186 $160,000
Q4 2022 Feb 10, 2023	SELL	$4.61 - $8.5 $44,504 - $82,059	-9,654 Reduced 5.76%	157,824 $953,000
Q3 2022 Nov 14, 2022	BUY	$5.0 - $8.82 $169,915 - $299,730	33,983 Added 25.46%	167,478 $1.11 Million
Q2 2022 Aug 12, 2022	SELL	$4.0 - $7.55 $6,968 - $13,152	-1,742 Reduced 1.29%	133,495 $696,000
Q1 2022 May 16, 2022	BUY	$6.9 - $13.22 $391,609 - $750,301	56,755 Added 72.32%	135,237 $933,000
Q4 2021 Feb 08, 2022	BUY	$11.89 - $31.74 $848,791 - $2.27 Million	71,387 Added 1006.16%	78,482 $977,000
Q3 2021 Nov 15, 2021	BUY	$25.78 - $38.65 $53,441 - $80,121	2,073 Added 41.28%	7,095 $222,000
Q2 2021 Sep 13, 2021	BUY	$28.63 - $44.3 $143,779 - $222,474	5,022 New	5,022 $145,000

Others Institutions Holding PRLD

# of Institutions

Shares Held

28.3M

Call Options Held

23.9K

Put Options Held

View Full List

About Prelude Therapeutics Inc

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $33.5M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

More about PRLD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Account

Bank Of America Corp Prelude Therapeutics Inc Transaction History